A detailed history of Intercontinental Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Intercontinental Wealth Advisors, LLC holds 9,362 shares of NVO stock, worth $817,957. This represents 0.36% of its overall portfolio holdings.

Number of Shares
9,362
Previous 9,778 4.25%
Holding current value
$817,957
Previous $1.56 Million 2.63%
% of portfolio
0.36%
Previous 0.4%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$155.98 - $172.65 $64,887 - $71,822
-416 Reduced 4.25%
9,362 $1.52 Million
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $267,062 - $321,144
-2,018 Reduced 17.11%
9,778 $1.56 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $466,089 - $615,074
-4,545 Reduced 27.81%
11,796 $1.6 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $33,157 - $40,691
-348 Reduced 2.09%
16,341 $1.63 Million
Q2 2022

Aug 05, 2022

SELL
$103.24 - $121.81 $108,711 - $128,265
-1,053 Reduced 5.94%
16,689 $1.86 Million
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $57,815 - $69,887
-621 Reduced 3.38%
17,742 $1.97 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $82,744 - $101,040
-863 Reduced 4.49%
18,363 $2.06 Million
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $424,885 - $536,618
-5,033 Reduced 20.75%
19,226 $1.85 Million
Q2 2021

Aug 06, 2021

BUY
$67.66 - $84.76 $115,157 - $144,261
1,702 Added 7.55%
24,259 $2.03 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $166,912 - $188,715
2,489 Added 12.4%
22,557 $1.52 Million
Q4 2020

Feb 19, 2021

BUY
$63.89 - $73.8 $510,353 - $589,514
7,988 Added 66.13%
20,068 $1.4 Million
Q3 2020

Mar 10, 2021

BUY
$63.69 - $70.22 $482,770 - $532,267
7,580 Added 168.44%
12,080 $839,000
Q3 2020

Jan 19, 2021

SELL
$63.69 - $70.22 $4,394 - $4,845
-69 Reduced 1.51%
4,500 $233,000
Q2 2020

Mar 10, 2021

BUY
$58.54 - $67.94 $267,469 - $310,417
4,569 New
4,569 $299,000
Q2 2020

Jan 19, 2021

SELL
$58.54 - $67.94 $263,430 - $305,730
-4,500 Closed
0 $0
Q1 2020

Mar 10, 2021

BUY
$49.46 - $64.78 $222,570 - $291,510
4,500 New
4,500 $271,000
Q1 2020

Jan 19, 2021

SELL
$49.46 - $64.78 $232,560 - $304,595
-4,702 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$49.86 - $58.26 $10,071 - $11,768
202 Added 4.49%
4,702 $303,000
Q3 2019

Oct 09, 2019

BUY
$47.54 - $53.43 $213,930 - $240,435
4,500 New
4,500 $233,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Intercontinental Wealth Advisors, LLC Portfolio

Follow Intercontinental Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.